A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
PHASE1
The main purpose of this research study is to determine the maximum tolerab...
A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection
PHASE3
To compare the impact on recurrence risk of adjuvant Sintilimab (a recombin...
Status
Not Yet Recruiting
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma
PHASE1
This is an open-label, multicenter, Phase Ib, dose-escalation and cohort-ex...